ALPS Medical Breakthroughs ETFSBIO
- AUM
- $193M
- Fee
- 0.50%
- Yield
- 0.0%
- Bumpy · 1Y
- 2.4×S&P
- Volume
- 22K
- NAV
- $57.55
52-week range19% below the high
$43.10$70.85
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | +3.3% | +7.8% | +4.7% | −14.2% | +12.5% | +30.1% | +138.3% | +25.8% | +151.9% |
| Peer average | +2.4% | +2.8% | +6.4% | +5.5% | +23.4% | +33.1% | +76.7% | +28.9% | — |
| S&P 500 · VOO | +2.3% | +0.1% | −3.3% | −2.1% | +11.3% | +13.6% | +81.6% | +75.4% | — |
SBIO in One Breath
SBIO Among Health Care ETFs
End-of-day Nov 10, 2026 · 33 Health care ETFs by YTD
$10,000 in SBIO
$10,000 in SBIO became
$12,582
In the S&P 500 (VOO)
$17,543
Total return, dividends in · Nov 1, 2021 – Nov 9, 2026 · S&P 500 uses VOO
SBIO’s Top Holdings
TodayORKAOruka Therapeutics4.5%CGON4.4%MANE3.8%EWTX3.2%DNTH3.2%TVTX3.1%DFTX2.9%RLAY2.7%XENE2.5%AMLX2.4%ACAD2.4%DYN2.2%VRDN2.1%DNLI2.1%IRON2.0%IDYA2.0%TARS2.0%ZLAB1.9%VCEL1.8%XNCR1.7%PVLA1.7%81 more
Biotechnology
ALPS SBIO · 103 holdings · tile size = share of the fund · as of Nov 9, 2026
What SBIO Holds
TodayBiotechnology93.1%
ORKA 4.5 · CGON 4.4 · MANE 3.8 · EWTX 3.2 · DNTH 3.2 · TVTX 3.1 · DFTX 2.9
Medical - Diagnostics & Research0.4%
FLGT
Medical - Devices0.3%
DCTH
Other holdings6.1%
MGTX · SLDB · AVBP · CADL · OLMA · DSGN · TECX
ALPS SBIO · share of the fund by industry · as of Nov 9, 2026
Oruka’s Share of SBIO
Today4.5%
$45 of every $1,000 in SBIO is Oruka
Oruka held by SBIO
$8.6M
ALPS SBIO · each square = $10 of $1,000 · as of Nov 9, 2026
SBIO’s Share of Health Care ETFs
Today0.2%
of the $110B in 39 Health care ETFs
$193M0.2%
$49.7B45.0%
$19.1B17.3%
$41.5B37.5%
Health care ETF AUM · Nov 10, 2026
SBIO Fee per $100 vs Peers
TodayExpense ratio · Health care peers · Nov 10, 2026
Inside SBIO
103 holdings · as of Nov 9, 2026SBIO
ALPS Medical Breakthroughs ETF
Today| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | ORKA | Oruka Therapeutics | 4.46% |
| 2 | CGON | CG oncology | 4.40% |
| 3 | MANE | VeraDermics | 3.80% |
| 4 | EWTX | Edgewise Therapeutics | 3.20% |
| 5 | DNTH | Dianthus Therapeutics | 3.15% |
| 6 | TVTX | Travere Therapeutics | 3.05% |
| 7 | DFTX | Definium Therapeutics | 2.92% |
| 8 | RLAY | Relay Therapeutics | 2.67% |
| 9 | XENE | Xenon Pharmaceuticals | 2.48% |
| 10 | AMLX | Amylyx Pharmaceuticals | 2.43% |
BiotechnologyMedical - DiagnosticsMedical - DevicesOther
ALPS SBIO · current holdings by weight · as of Nov 9, 2026 · each tile is one holding · top 20 = 52.8%
All SBIO Holdings
104 holdings · as of Nov 9, 2026SBIO
SBIO’s Holdings
Today| # | ||||||
|---|---|---|---|---|---|---|
| 1 | ORKAOruka Therapeutics | Healthcare | 4.46% | $445.67 | 81K | $8.3M |
| 2 | CGONCG oncology | Healthcare | 4.40% | $440.47 | 108K | $8.2M |
| 3 | MANEVeraDermics | Healthcare | 3.80% | $379.79 | 51K | $7.1M |
| 4 | EWTXEdgewise Therapeutics | Healthcare | 3.20% | $319.87 | 133K | $6.0M |
| 5 | DNTHDianthus Therapeutics | Healthcare | 3.15% | $315.08 | 68K | $5.9M |
| 6 | TVTXTravere Therapeutics | Healthcare | 3.05% | $305.47 | 115K | $5.7M |
| 7 | DFTXDefinium Therapeutics | Healthcare | 2.92% | $292.27 | 164K | $5.5M |
| 8 | RLAYRelay Therapeutics | Healthcare | 2.67% | $266.98 | 268K | $5.0M |
| 9 | XENEXenon Pharmaceuticals | Healthcare | 2.48% | $248.44 | 119K | $4.6M |
| 10 | AMLXAmylyx Pharmaceuticals | Healthcare | 2.43% | $242.56 | 154K | $4.5M |
| 11 | ACADACADIA Pharmaceuticals | Healthcare | 2.39% | $239.07 | 210K | $4.5M |
| 12 | DYNDyne Therapeutics | Healthcare | 2.21% | $221.03 | 229K | $4.1M |
| 13 | VRDNViridian Therapeutics | Healthcare | 2.11% | $211.39 | 139K | $4.0M |
| 14 | DNLIDenali Therapeutics | Healthcare | 2.10% | $210.14 | 196K | $3.9M |
| 15 | IRONDisc Medicine | Healthcare | 1.98% | $198.39 | 47K | $3.7M |
ALPS SBIO · every reported holding · per $10,000 = dollars of each holding in a $10,000 stake · as of Nov 9, 2026
How It Compares
SBIO
ALPS Medical Breakthroughs ETF’s Peers
YTDHealth care peers · YTD and past-year returns · as of Nov 10, 2026 · sorted by AUM
Head to Head
Put SBIO head to head with XLV →XLV vs SBIO
YTDYear to date
XLV wins+10.7 pts
Past year
XLV wins+1.1 pts
Fee
XLV winslower fee
Yield
XLV wins+1.4 pts
AUM
XLV257.7× more
4–0XLV wins
SPDR XLV and ALPS SBIO · year-to-date · as of Nov 10, 2026 · AUM not scored
SBIO vs VOO
YTDSBIO · ALPS Medical Breakthroughs
+12.5%
VOO · S&P 500
+11.3%
Gap
1.2 pts
ALPS SBIO and Vanguard VOO · YTD total return · as of Nov 10, 2026
SBIO vs Its Peer Average
YTDSBIOAvsBPeer average
1D+3.3%+2.4%
1M+4.7%+6.4%
3M−14.2%+5.5%
YTD+12.5%+23.4%
1Y+30.1%+33.1%
3Y+138.3%+76.7%
5Y+25.8%+28.9%
2–5Peer average wins
38 Health care peers · each row scaled to its leader
How Bumpy Is SBIO?
ViewSBIO
How Bumpy
1Y2.4×the S&P 500’s swings
CalmerBumpierS&P 1×SBIO
Bumpiest of 7 health care fundsSBIO
Other health care funds1.2× to 2.2×
ALPS SBIO · daily swings over the past year vs the S&P 500
SBIO
Worst Drop
1Y−29.2%from its Aug 19 high
Still below the high−18.6%
$10,000 at the high is now$8,140
ALPS SBIO · fall from the highest close, past year
SBIO
On a Bad Day
1Y1.0×the S&P 500’s fall
SBIO’s worst day: Wednesday, Sep 23Up days53 of every 100
S&P 500 up days52 of every 100
ALPS SBIO · average move on days the S&P 500 fell
SBIO
Return for the Bumps
1Y#6 of 7 health care fundsRanked by return above cash for each unit of bumpiness (Sharpe ratio) · cash = 3.8%
SBIO
Cost
Today$50a year per $10,000
Expense ratio 0.50%, taken from the fund’s value
SBIO
Volatility & Beta
1Y33.4%annual volatility
S&P 500 volatility13.7%
Downside volatility22.0%
Beta vs SPY1.11
Correlation vs SPY0.45
Beta rank, lowest first, of 7#6
Daily total returns × √252 · past 254 trading days
SBIO
Max Drawdown
1Y−29.2%peak to trough
Peak closeAug 19, 2026
Current drawdown−18.6%
Worst day−5.52% · Sep 23
Closing prices, dividends in
SBIO
Up / Down Capture
1Y96%down capture vs SPY
Up ÷ down capture1.25
Up days52.8% (S&P 52.4%)
Average daily move on SPY up days and down days
SBIO
Sharpe & Sortino vs Peers
1YSharpe = (return − 3.8% cash) ÷ volatility · Sortino uses downside volatility only
SBIO
Trading
Today+0.09%above its holdings’ value
Close$57.60
NAV$57.55
Fee per $10,000$50 a year
Avg. volume 30D33K shares
Close vs net asset value, Nov 9
The Details
SBIO
Fund Facts
Today2014launched Dec 30
Tracks[…]
Exchange · CUSIPAMEX · 00162Q593
StructureETF
Leverage1x
Cost on $10,000$50 a year
Go deeper
ALPS SBIO · fund facts · as of Nov 10, 2026
SBIO
Payouts by Year
5Y$1.17per share, Dec 2024
Distribution yield0.0%
PaidOnce a year, in December
Latest ex-date · paidDec 19 · Dec 26, 2024
5 payouts added up$2.62 a share
ALPS SBIO · distributions by ex-date · 2017–2024
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
SEC reported portfolio · 2026-08-31 ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2026-05-31 ↗SEC reported portfolio · 2026-02-28 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-11-30 ↗SEC reported portfolio · 2025-08-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-05-31 ↗SEC reported portfolio · 2025-02-28 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-11-30 ↗SEC reported portfolio · 2024-08-31 ↗SEC reported portfolio · 2024-05-31 ↗SEC reported portfolio · 2024-02-29 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2023-11-30 ↗SEC reported portfolio · 2023-08-31 ↗SEC reported portfolio · 2023-05-31 ↗SEC reported portfolio · 2023-02-28 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2022-11-30 ↗SEC reported portfolio · 2022-08-31 ↗SEC reported portfolio · 2022-05-31 ↗SEC reported portfolio · 2022-02-28 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2021-11-30 ↗SEC reported portfolio · 2021-08-31 ↗SEC reported portfolio · 2021-05-31 ↗SEC reported portfolio · 2021-02-28 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2020-11-30 ↗SEC reported portfolio · 2020-08-31 ↗SEC reported portfolio · 2020-05-31 ↗
Trading & Liquidity
Net asset value$57.55
Premium / discount[…]
Median spread · 30D[…]
Volume today22K
Average volume · 30D33K
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.50%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$50.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 19, 2024 | Dec 26, 2024 | $1.17 |
| Dec 21, 2023 | Dec 27, 2023 | $0.0711 |
| Dec 19, 2019 | Dec 27, 2019 | $0.0160 |
| Dec 20, 2018 | Dec 27, 2018 | $0.78 |
| Dec 21, 2017 | Dec 28, 2017 | $0.58 |
Issuer contentFrom ALPSHear the strategy from the people behind SBIO.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →